Conformis Inc (CFMS) Stock Price, Quote, News and Overview
NASDAQ:CFMS - Nasdaq - US20717E2000 - Common Stock - Currency: USD
CFMS Quote, Performance and Key Statistics
2.26
0 (0%)
The current stock price of CFMS is 2.26 USD. In the past month the price increased by 0.89%. In the past year, price decreased by -65.23%.
CFMS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About CFMS
Company Profile
ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. The company is headquartered in Billerica, Massachusetts and currently employs 295 full-time employees. The company went IPO on 2015-07-01. The firm is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The firm offers knee replacement products and knee replacement products. The firm's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The firm owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
Company Info
Conformis Inc
600 Technology Drive
Billerica MASSACHUSETTS 01821 US
CEO: Mark A. Augusti
Employees: 295
Company Website: http://www.conformis.com/
Phone: 17813459001.0
Conformis Inc / CFMS FAQ
What is the stock price of Conformis Inc today?
The current stock price of CFMS is 2.26 USD.
What is the ticker symbol for Conformis Inc stock?
The exchange symbol of Conformis Inc is CFMS and it is listed on the Nasdaq exchange.
On which exchange is CFMS stock listed?
CFMS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for Conformis Inc stock?
8 analysts have analysed CFMS and the average price target is 2.32 USD. This implies a price increase of 2.45% is expected in the next year compared to the current price of 2.26. Check the Conformis Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Conformis Inc worth?
Conformis Inc (CFMS) has a market capitalization of 17.80M USD. This makes CFMS a Nano Cap stock.
How many employees does Conformis Inc have?
Conformis Inc (CFMS) currently has 295 employees.
What are the support and resistance levels for Conformis Inc (CFMS) stock?
Conformis Inc (CFMS) has a support level at 2.26 and a resistance level at 2.27. Check the full technical report for a detailed analysis of CFMS support and resistance levels.
Is Conformis Inc (CFMS) expected to grow?
The Revenue of Conformis Inc (CFMS) is expected to decline by -8.57% in the next year. Check the estimates tab for more information on the CFMS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy Conformis Inc (CFMS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CFMS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CFMS, evaluating the profitability, health, valuation and growth aspects
- Conformis Inc (CFMS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Conformis Inc (CFMS) Sales and EPS estimates to see what analysts future expectations are.
- Conformis Inc (CFMS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Conformis Inc (CFMS) Insider and Institutional Ownership to learn about the owners and their transactions.
- Conformis Inc (CFMS) Stock Chart to make your own analysis
- Conformis Inc (CFMS) Latest news and press-releases to stay up to date.
Does Conformis Inc (CFMS) stock pay dividends?
CFMS does not pay a dividend.
When does Conformis Inc (CFMS) report earnings?
Conformis Inc (CFMS) will report earnings on 2023-10-31, after the market close.
What is the Price/Earnings (PE) ratio of Conformis Inc (CFMS)?
Conformis Inc (CFMS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.61).
CFMS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to CFMS. When comparing the yearly performance of all stocks, CFMS is one of the better performing stocks in the market, outperforming 89.18% of all stocks.
CFMS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CFMS. CFMS may be in some trouble as it scores bad on both profitability and health.
CFMS Financial Highlights
Over the last trailing twelve months CFMS reported a non-GAAP Earnings per Share(EPS) of -5.61. The EPS increased by 34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.64 |
CFMS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to CFMS. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 24.27% and a revenue growth -8.57% for CFMS